Gardasil Granted Priority Review
This article was originally published in The Pink Sheet Daily
Executive Summary
Merck's human papillomavirus vaccine Gardasil has been granted priority review by FDA, the company announced Feb. 7
You may also be interested in...
Merck Gardasil Slated For Advisory Committee Review May 18
Vaccines & Related Biological Products committee will review HPV vaccine less than a month ahead of June 8 priority review user fee date.
Merck Gardasil Slated For Advisory Committee Review May 18
Vaccines & Related Biological Products committee will review HPV vaccine less than a month ahead of June 8 priority review user fee date.
Cervarix Reimbursement Will Be Key Challenge For Adoption, GSK Says
GlaxoSmithKline plans to submit a BLA for the human papillomavirus vaccine by year-end.